Tempest Therapeutics (TPST) Tax Provisions (2015 - 2025)

Tempest Therapeutics has disclosed Tax Provisions across 8 years of filings, most recently posting -$5.5 million for Q4 2025.

• In Q4 2025, Tax Provisions rose 37.24% year-over-year to -$5.5 million; the TTM figure through Jun 2026 stood at -$5.5 million (up 37.24% YoY), while the FY2025 annual figure was -$5.5 million, up 37.24% from the prior year.
• Tax Provisions came in at -$5.5 million for Q4 2025 at Tempest Therapeutics, up from -$8.8 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of -$5.5 million in Q4 2025 to a low of -$8.8 million in Q4 2024.
• Average Tax Provisions over 5 years is -$6.8 million, with a median of -$6.2 million recorded in 2023.
• Year-over-year, Tax Provisions sank 41.89% in 2024 and surged 37.24% in 2025.
• Over 5 years, Tax Provisions stood at -$5.9 million in 2021, then dropped by 26.94% to -$7.5 million in 2022, then gained by 17.41% to -$6.2 million in 2023, then slumped by 41.89% to -$8.8 million in 2024, then surged by 37.24% to -$5.5 million in 2025.
• Per Business Quant data, the three most recent Tax Provisions figures were -$5.5 million in Q4 2025, -$8.8 million in Q4 2024, and -$6.2 million in Q4 2023.